CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer.
Chen W, Wu Y, Yang C, Ren W, Hou L, Liang H, Wu T, Kong Y, Wu J, Rao Y, Chen C.
Chen W, et al. Among authors: liang h.
Biomed Pharmacother. 2024 Jun 20;177:116972. doi: 10.1016/j.biopha.2024.116972. Online ahead of print.
Biomed Pharmacother. 2024.
PMID: 38906024